Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Birkenæs V, Parekh P, Hegemann L, Bakken NR, Frei E, Jaholkowski P, Smeland OB, Susser E, Rodriguez KM, Tesfaye M, Andreassen OA, Havdahl A, Sønderby IE(2025) Youth psychotic experiences: psychometric evaluation and diagnostic associations of the CAPE-16 in adolescents from the Norwegian Mother, Mather and Child Cohort J Child Psychol Psychiatry(in press) DOI 10.1111/jcpp.70007, PubMed 40759589
Arnesen EK, Christensen JJ, Laake I, Carlsen MH, Veierød MB, Retterstøl K(2025) Low-fat and Whole Milk Consumption in relation to Cardiovascular and All-Cause Mortality: A prospective cohort study in three Norwegian counties Am J Clin Nutr(in press) DOI 10.1016/j.ajcnut.2025.07.035, PubMed 40759395
Cyll K, Skrede OJ, Kleppe A(2025) Can radiology be first to use prognostic deep learning models for oncological treatment? Ann Oncol(in press) DOI 10.1016/j.annonc.2025.07.013, PubMed 40754034